Tumor-expressed IDO recruits and activates MDSCs in a Treg-dependent manner Journal Article


Authors: Holmgaard, R. B.; Zamarin, D.; Li, Y.; Gasmi, B.; Munn, D. H.; Allison, J. P.; Merghoub, T.; Wolchok, J. D.
Article Title: Tumor-expressed IDO recruits and activates MDSCs in a Treg-dependent manner
Abstract: Indoleamine 2,3-dioxygenase (IDO) has been described as a major mechanism of immunosuppression in tumors, though the mechanisms of this are poorly understood. Here, we find that expression of IDO by tumor cells results in aggressive tumor growth and resistance to T-cell-targeting immunotherapies. We demonstrate that IDO orchestrates local and systemic immunosuppressive effects through recruitment and activation of myeloid-derived suppressor cells (MDSCs), through a mechanism dependent on regulatory T cells (Tregs). Supporting these findings, we find that IDO expression in human melanoma tumors is strongly associated with MDSC infiltration. Treatment with a selective IDO inhibitor in vivo reversed tumor-associated immunosuppression by decreasing numbers of tumor-infiltrating MDSCs and Tregs and abolishing their suppressive function. These findings establish an important link between IDO and multiple immunosuppressive mechanisms active in the tumor microenvironment, providing a strong rationale for therapeutic targeting of IDO as one of the central regulators of immune suppression. © 2015 The Authors.
Journal Title: Cell Reports
Volume: 13
Issue: 2
ISSN: 2211-1247
Publisher: Cell Press  
Date Published: 2015-10-13
Start Page: 412
End Page: 424
Language: English
DOI: 10.1016/j.celrep.2015.08.077
PROVIDER: scopus
PUBMED: 26411680
PMCID: PMC5013825
DOI/URL:
Notes: Export Date: 2 November 2015 -- Source: Scopus
Altmetric
Citation Impact
MSK Authors
  1. Jedd D Wolchok
    898 Wolchok
  2. Taha Merghoub
    358 Merghoub
  3. Dmitriy Zamarin
    194 Zamarin
  4. Yanyun Li
    42 Li
  5. Billel Gasmi
    18 Gasmi